Prof Leon AaronsBSc, MSc, PhD

Professor

Full contact details
View graph of relations

Publications

  1. Published

    Population pharmacokinetics of ritonavir-boosted saquinavir regimens in HIV-infected individuals

    Dickinson, L., Boffito, M., Back, D. J., Khoo, S. H., Pozniak, A. L., Mugyenyi, P., Merry, C., Autar, R. S., Burger, D. M. & Aarons, L. J., 2008, In : Journal of Antimicrobial Chemotherapy. 62, 6, p. 1344-1355 11 p.

    Research output: Contribution to journalArticle

  2. Published

    Population pharmacokinetics of rufloxacin in patients with acute exacerbations of chronic bronchitis

    Imbimbo, B. P., Klietmann, W., Broccali, G. P., Cesana, M. & Aarons, L., 1 Jan 1997, In : European Journal of Pharmaceutical Sciences. 5, 1, p. 37-42 5 p.

    Research output: Contribution to journalArticle

  3. Published

    Population Pharmacokinetics of Selumetinib and Its Metabolite N-desmethyl-selumetinib in Adult Patients With Advanced Solid Tumors and Children With Low-Grade Gliomas

    Patel, Y. T., Daryani, V. M., Patel, P., Zhou, D., Fangusaro, J., Carlile, D. J., Martin, P. D., Aarons, L. & Stewart, C. F., 2017, In : CPT: Pharmacometrics and Systems Pharmacology.

    Research output: Contribution to journalArticle

  4. Published

    Population pharmacokinetics of the MEK inhibitor selumetinib and its active N-desmethyl metabolite: Data from 10 phase I trials

    Patel, P., Howgate, E., Martin, P., Carlile, D. J., Aarons, L. & Zhou, D., 2017, In : British Journal of Clinical Pharmacology.

    Research output: Contribution to journalArticle

  5. Published

    Population pharmacokinetics of tiagabine in epileptic patients on monotherapy

    Ingwersen, S. H., Pedersen, P. C., Groes, L., Nielsen, K. K. & Aarons, L., Sep 2000, In : European Journal of Pharmaceutical Sciences. 11, 3, p. 247-254 7 p.

    Research output: Contribution to journalArticle

  6. Published

    Practical experience and issues in designing and performing population pharmacokinetic/pharmacodynamic studies

    Aarons, L., Rowland, M., Balant, L. P., Mentré, F., Morselli, P. L., Steimer, J. L. & Vozeh, S., Jan 1996, European Journal of Clinical Pharmacology|Eur J Clin Pharmacol. Springer Nature, Vol. 49. p. 251-254 3 p.

    Research output: Chapter in Book/Report/Conference proceedingConference contribution

  7. Published

    Precision criteria to derive sample size when designing pediatric pharmacokinetic studies: Which measure of variability should be used?

    Salem, F., Ogungbenro, K., Vajjah, P., Johnson, T. N., Aarons, L. & Rostami-Hodjegan, A., 2014, In : Journal of Clinical Pharmacology. 54, 3, p. 311-317 6 p.

    Research output: Contribution to journalArticle

  8. Published

    Predicting survival of pancreatic cancer patients treated with gemcitabine using longitudinal tumour size data

    Wendling, T., Mistry, H., Ogungbenro, K. & Aarons, L., 7 Mar 2016, In : Cancer Chemotherapy and Pharmacology. 77, 5, p. 927 938 p., 11.

    Research output: Contribution to journalArticle

  9. Published

    Prediction of serum tobramycin in patients with NONMEM and simulated annealing.

    Mengov, G., St, H. & Aarons, L., 2003, In : Comptes Rendus de l'Academie Bulgare des Sciences.. 56, 5, p. 47-50

    Research output: Contribution to journalArticle

  10. Published

    Propagation of population pharmacokinetic information using a Bayesian approach: Comparison with meta-analysis

    Dokoumetzidis, A. & Aarons, L., Aug 2005, In : Journal of pharmacokinetics and pharmacodynamics. 32, 3-4, p. 401-418 17 p.

    Research output: Contribution to journalArticle